基于肠促胰岛素的抗糖尿病药物发展概况(4)
[17] Nauck MA， Ratner RE， Kapitza C， et al. Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone： a double-blind placebo-controlled study [J]. Diabetes Care ......
您现在查看是摘要页，全文长 2657 字符。